NO961622L - Inhibition of photo-cleavage of 3-substituted 2-oxindoles - Google Patents
Inhibition of photo-cleavage of 3-substituted 2-oxindolesInfo
- Publication number
- NO961622L NO961622L NO961622A NO961622A NO961622L NO 961622 L NO961622 L NO 961622L NO 961622 A NO961622 A NO 961622A NO 961622 A NO961622 A NO 961622A NO 961622 L NO961622 L NO 961622L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- oxindoles
- cleavage
- inhibition
- photo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polymerisation Methods In General (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
Oppfinnelsen angår beskyttelsen av visse 3-substituerte- 2-oksindol-l-karboksamider med formel og deres farmasøytisk akseptable basesalter, hvor X er H, Cl eller F; Y er H eller Cl; og R er benzyl eller tienyl, hver eventuelt substituert med Cl eller F, mot en spaltning i nærvær av lys.The invention relates to the protection of certain 3-substituted-2-oxindole-1-carboxamides of formula and their pharmaceutically acceptable base salts, wherein X is H, Cl or F; Y is H or Cl; and R is benzyl or thienyl, each optionally substituted with Cl or F, against a decomposition in the presence of light.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB1995/000287 WO1996033701A1 (en) | 1995-04-24 | 1995-04-24 | Inhibiting photodecomposition of 3-substituted-2-oxindoles |
Publications (2)
Publication Number | Publication Date |
---|---|
NO961622D0 NO961622D0 (en) | 1996-04-23 |
NO961622L true NO961622L (en) | 1996-10-25 |
Family
ID=36997502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961622A NO961622L (en) | 1995-04-24 | 1996-04-23 | Inhibition of photo-cleavage of 3-substituted 2-oxindoles |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP0827399A1 (en) |
JP (1) | JPH10506635A (en) |
KR (1) | KR100189585B1 (en) |
CN (1) | CN1053667C (en) |
AP (1) | AP607A (en) |
AR (1) | AR002728A1 (en) |
AU (1) | AU692378B2 (en) |
BG (1) | BG100531A (en) |
BR (1) | BR9602024A (en) |
CO (1) | CO4700418A1 (en) |
FI (1) | FI973988A0 (en) |
HR (1) | HRP960194A2 (en) |
HU (1) | HU216544B (en) |
IL (1) | IL117969A0 (en) |
IS (1) | IS4339A (en) |
MA (1) | MA23848A1 (en) |
NO (1) | NO961622L (en) |
NZ (1) | NZ286432A (en) |
OA (1) | OA10286A (en) |
PE (1) | PE34397A1 (en) |
RO (1) | RO113305B1 (en) |
RU (1) | RU2109510C1 (en) |
SG (1) | SG64924A1 (en) |
SI (1) | SI9600133A (en) |
SK (1) | SK51296A3 (en) |
TR (1) | TR199600300A2 (en) |
UA (1) | UA42739C2 (en) |
WO (1) | WO1996033701A1 (en) |
YU (1) | YU25096A (en) |
ZA (1) | ZA963210B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021510067A (en) | 2017-12-29 | 2021-04-15 | クラフト・フーズ・グループ・ブランズ・エルエルシー | Improved oxidative stability of oil-in-water emulsions using natural stabilizers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT59592A (en) * | 1990-07-20 | 1992-06-29 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of solid medical products |
TW438798B (en) * | 1992-10-07 | 2001-06-07 | Pfizer | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
-
1995
- 1995-04-24 UA UA96041574A patent/UA42739C2/en unknown
- 1995-04-24 WO PCT/IB1995/000287 patent/WO1996033701A1/en not_active Application Discontinuation
- 1995-04-24 EP EP95914494A patent/EP0827399A1/en not_active Ceased
- 1995-04-24 JP JP8532298A patent/JPH10506635A/en active Pending
- 1995-04-24 RU RU96108120A patent/RU2109510C1/en active
- 1995-04-24 SK SK512-96A patent/SK51296A3/en unknown
-
1996
- 1996-03-07 AP APAP/P/1996/000787A patent/AP607A/en active
- 1996-03-28 AR ARP960101956A patent/AR002728A1/en unknown
- 1996-04-10 TR TR96/00300A patent/TR199600300A2/en unknown
- 1996-04-18 IL IL11796996A patent/IL117969A0/en unknown
- 1996-04-19 SG SG1996009306A patent/SG64924A1/en unknown
- 1996-04-19 IS IS4339A patent/IS4339A/en unknown
- 1996-04-22 CO CO96019210A patent/CO4700418A1/en unknown
- 1996-04-22 CN CN96105084A patent/CN1053667C/en not_active Expired - Fee Related
- 1996-04-22 PE PE1996000275A patent/PE34397A1/en not_active Application Discontinuation
- 1996-04-22 RO RO96-00843A patent/RO113305B1/en unknown
- 1996-04-23 NZ NZ286432A patent/NZ286432A/en unknown
- 1996-04-23 BG BG100531A patent/BG100531A/en unknown
- 1996-04-23 NO NO961622A patent/NO961622L/en unknown
- 1996-04-23 ZA ZA9603210A patent/ZA963210B/en unknown
- 1996-04-23 KR KR1019960012356A patent/KR100189585B1/en not_active IP Right Cessation
- 1996-04-23 HU HU9601057A patent/HU216544B/en not_active IP Right Cessation
- 1996-04-23 YU YU25096A patent/YU25096A/en unknown
- 1996-04-23 AU AU50851/96A patent/AU692378B2/en not_active Ceased
- 1996-04-23 MA MA24209A patent/MA23848A1/en unknown
- 1996-04-23 HR HRPCT/IB95/00287A patent/HRP960194A2/en not_active Application Discontinuation
- 1996-04-24 BR BR9602024A patent/BR9602024A/en active Search and Examination
- 1996-04-24 SI SI9600133A patent/SI9600133A/en not_active IP Right Cessation
- 1996-04-24 OA OA60821A patent/OA10286A/en unknown
-
1997
- 1997-10-17 FI FI973988A patent/FI973988A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2004004I1 (en) | Bortezomib or a pharmaceutically acceptable ester thereof, optionally in the form of a pharmaceutically acceptable salt thereof | |
DK0658198T3 (en) | Multicistronic expression units as well as their use | |
CA2189007A1 (en) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof | |
DK0977741T3 (en) | Substituted phenyl derivatives, their preparation and use | |
DE69425162D1 (en) | 4,5-DIARYLOXAZOLE DERIVATIVES | |
MY114393A (en) | 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1, 3-propanediol derivatives | |
MC2263A1 (en) | AMINOBENZODIAZEPINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | |
DK231088D0 (en) | PIPERIDE CONNECTIONS, THEIR PREPARATION AND USE | |
IT1295933B1 (en) | 2- (2'-HYDROXYPHENYL) BENZOTHRIAZOLS AND PROCEDURE FOR THEIR PREPARATION | |
DE69903053D1 (en) | DIAMINOCYCLOBUTEN-3,4-DIONE DERIVATIVES, THEIR PRODUCTION AND THEIR USE | |
DE69630391D1 (en) | PROLYLENDOPEPTIDASE INHIBITORS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE | |
DE69514284T2 (en) | Manufacture of catechol-estrogen derivatives | |
DE69325073T2 (en) | Borazine derivatives of hydridopolysilazane polymers | |
NO911459D0 (en) | USE OF METALLION COMPLEXS AS INVESTMENT INHIBITORS. | |
DE69327813D1 (en) | Alpha-glucosyl-catecholamine derivatives, their salts, production and use | |
DE69213862T2 (en) | Manufacture of aluminoxanes | |
DE69415801T2 (en) | EMERGENCY PROTECTION HOUSE | |
NO961236D0 (en) | Pyrrolodiazine derivatives as stabilizers for chlorine-containing polymerisates | |
NO961622L (en) | Inhibition of photo-cleavage of 3-substituted 2-oxindoles | |
AU621634B2 (en) | Glycerin derivative and its pharmacological use | |
DE69611303D1 (en) | BENZOLSULPHONAMIDE DERIVATIVES, THEIR PRODUCTION AND THEIR THERAPEUTIC USE | |
FI941380A (en) | Phenylglycinamides of heterocyclic substituted phenylacetic acid derivatives | |
DE69313168D1 (en) | Crystalline substituted stannosilicates, their production and use | |
DE69502982D1 (en) | Production of protected aminothiazolylacetic acid derivatives | |
NO940131D0 (en) | Salts of 4-pyrimidinone derivatives for framasoytic use |